Home > Publications > Hong Kong Medical Journal

Hong Kong Medical Journal

Hong Kong Medical Journal is the official peer-reviewed publication of the Hong Kong Academy of Medicine and the Hong Kong Medical Association. It is indexed in Medline/Index Medicus and Embase/Excerpta Medica, and is published bimonthly by the

Hong Kong Academy of Medicine Press

The Journal is currently circulated to all Fellows of the Academy, members of the Association and other medical institutions. It is also available to non-members on subscription.

 For more information, please visit the Journal website: http://www.hkmj.org   

 


Hong Kong Medical Journal
Hong Kong Medical Journal


Latest articles available at www.hkmj.org:

Original Article  
Outcomes of a pharmacist-led medication review programme for hospitalised elderly patients
Having clinical pharmacists perform standard checking procedures can enhance the safety and quality of prescriptions for elderly in-patients, report Patrick KC Chiu et al. After implementing a pharmacist-led medication review programme in a geriatric unit of a local hospital from December 2013 to September 2014, the research team found a significant reduction in the use of inappropriate medications among hospitalised elderly patients, as well as in all-cause unscheduled readmissions within 1 month of hospital discharge.
Hong Kong Med J 2018 Apr;24(2):98–106 | Epub 9 Feb 2018
 
   
Original Article  
Outcomes and morbidities of patients who survive haemoglobin Bart’s hydrops fetalis syndrome: 20-year retrospective review
In the first local report of all known survivors of haemoglobin Bart’s hydrops fetalis syndrome, a once-considered fatal disease, Wilson YK Chan et al systematically review antenatal care, counselling, and diagnosis; perinatal and long-term treatments; and short- and long-term complications. By studying records from eight public-hospital paediatric haematology units, the authors identified nine locally born patients who survived the syndrome, two of whom underwent stem-cell transplantation and have become transfusion-independent.
Hong Kong Med J 2018 Apr;24(2):107–18 | Epub 6 Apr 2018
 
   
Original Article  
Intra-operative periarticular multimodal injection in total knee arthroplasty: a local hospital experience in Hong Kong
Pain management after total knee replacement for knee osteoarthritis is more effective if an extra injection step is added during the operation, Jason CH Fan has found after reviewing patient records of a local hospital between 2005 and 2012. From June 2009, injections of a drug cocktail (including levobupivacaine, morphine, and adrenaline) around the joint were added to the routine intra-operative procedure. Compared with patients before that date, patients receiving the extra injections used significantly less patient-controlled analgesia morphine in the first 36 hours after surgery.
Hong Kong Med J 2018 Apr;24(2):145–51 | Epub 14 Mar 2018

Image: HKAM Press
   
Original Article  
Bacteriology and risk factors associated with periprosthetic joint infection after primary total knee arthroplasty: retrospective study of 2543 cases
In the past two decades of primary elective surgery for total knee replacement in Hong Kong, the occurrence of infection around the artificial knee after surgery has been low, according to a retrospective study by KT Siu et al. The incidence of periprosthetic joint infection was 1.34% (34/2543), and rheumatoid arthritis was the only consistent factor identified in the series to be significantly associated with joint infection.
Hong Kong Med J 2018 Apr;24(2):152–7 | Epub 29 Mar 2018
   
Original Article  
Endobronchial valve for treatment of persistent air leak complicating spontaneous pneumothorax
Patients underdoing chest-tube drainage for spontaneous pneumothorax may experience persistent air leakage but may not opt or be able to have remedial surgery. However, the alternative—fitting an endobronchial one-way valve—has a low success rate, according to WC Wu et al. The researchers report that only about a fifth (22%) of cases of air leakage treated with an endobronchial valve had “unequivocal success” among 37 patients in an 8-year period. They then analyse which factors were associated with treatment success and failure.
Hong Kong Med J 2018 Apr;24(2):158–65 | Epub 4 Apr 2018

Image: HKAM Press


Information for